Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

(2011) James B. Dale et al.   VACCINE

Comparison of rhesus and cynomolgus macaques in a Streptococcus pyogenes infection model for vaccine evaluation

(2010) Julie M. Skinner et al.   MICROBIAL PATHOGENESIS

Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate

(2010) Anna Kabanova et al.   VACCINE

Overview of the development and current use of CRM197 conjugate vaccines for pediatric use

(2010) Henry R. Shinefield   VACCINE

Global emm type distribution of group A streptococci: systematic review and implications for vaccine development

(2009) Andrew C Steer et al.   LANCET INFECTIOUS DISEASES

A vaccine against S. pyogenes: Design and experimental immune response

(2009) L. Guilherme et al.   METHODS

Increasing telithromycin resistance among Streptococcus pyogenes in Europe

(2008) S. S. Richter et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Amino Acid Analysis of Peptide Loading Ratios in Conjugate Vaccines: A Comparison of Direct Electrochemical Detection and 6-Aminoquinolyl-N-Hydroxysuccinimidyl Carbamate Pre-Column Derivatization Methods

(2007) Deborah D. Nahas et al.   BIOCONJUGATE CHEMISTRY